11-5967825-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001146033.1(OR56A5):āc.670A>Gā(p.Ile224Val) variant causes a missense change. The variant allele was found at a frequency of 0.000304 in 1,565,686 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00032 ( 0 hom., cov: 33)
Exomes š: 0.00030 ( 1 hom. )
Consequence
OR56A5
NM_001146033.1 missense
NM_001146033.1 missense
Scores
2
4
5
Clinical Significance
Conservation
PhyloP100: 3.73
Genes affected
OR56A5 (HGNC:14792): (olfactory receptor family 56 subfamily A member 5) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.035336047).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR56A5 | NM_001146033.1 | c.670A>G | p.Ile224Val | missense_variant | 1/1 | ENST00000532411.2 | |
OR56A3 | XM_047426926.1 | c.*468+19063T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR56A5 | ENST00000532411.2 | c.670A>G | p.Ile224Val | missense_variant | 1/1 | NM_001146033.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000316 AC: 48AN: 152068Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
48
AN:
152068
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000284 AC: 50AN: 175888Hom.: 0 AF XY: 0.000301 AC XY: 28AN XY: 92936
GnomAD3 exomes
AF:
AC:
50
AN:
175888
Hom.:
AF XY:
AC XY:
28
AN XY:
92936
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000303 AC: 428AN: 1413500Hom.: 1 Cov.: 31 AF XY: 0.000312 AC XY: 218AN XY: 698390
GnomAD4 exome
AF:
AC:
428
AN:
1413500
Hom.:
Cov.:
31
AF XY:
AC XY:
218
AN XY:
698390
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000315 AC: 48AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74392
GnomAD4 genome
AF:
AC:
48
AN:
152186
Hom.:
Cov.:
33
AF XY:
AC XY:
20
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
27
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 22, 2023 | The c.670A>G (p.I224V) alteration is located in exon 1 (coding exon 1) of the OR56A5 gene. This alteration results from a A to G substitution at nucleotide position 670, causing the isoleucine (I) at amino acid position 224 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MutationAssessor
Pathogenic
.;H
PrimateAI
Benign
T
Sift4G
Uncertain
D;D
Polyphen
1.0
.;D
Vest4
0.61
MVP
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at